UNSPSC 51151648: Mebeverine

This classification denotes an anticholinergic agent with the molecular formula C25H35NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7F80CC3NNV, chemically known as 4-(ethyl(2-(4-methoxyphenyl)-1-methylethyl)amino)butyl 3,4-dimethoxybenzoate but generally known as mebeverine, which bears US NIH Compound Identifier 4031. European Medicines Agency schedules Mebeverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08662MIG.

UNSPSC 51151648 Mebeverine, a Commodity code, shows minimal recent state and local activity directly aligned with its nominal scope. The two recent opportunities tagged to this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs—do not represent procurement of mebeverine itself, a gastrointestinal antispasmodic medication. The naloxone solicitation addresses opioid-response supplies, and the Texas RFI addresses pharmacy benefit program architecture. Neither matches the specific pharmaceutical product this code nominally describes. State and local procurement offices appear to be using the code incorrectly, or the opportunities have been misclassified in the source.

The mismatch between the code's intended scope and the tagged opportunities suggests that pursuing business under UNSPSC 51151648 based on recent activity would target the wrong customer needs and product categories. A firm selling mebeverine or other gastrointestinal pharmaceuticals should verify the actual UNSPSC codes state and local health departments, pharmacy benefit programs, and procurement offices use when soliciting these products, as the current code's recent record does not reflect genuine demand signals for that product line.